BlackRock’s Plus Therapeutics PSTV Stock Holding History

BlackRock’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$289K	Hold	71,055	–	–	﹤0.01%	4663
2025 Q4	$910K	Buy	71,055 +52,279	+278%	+$788K	﹤0.01%	4329
2025 Q3	$321K	Buy	18,776 +18,498	+6,654%	+$227K	﹤0.01%	4572
2025 Q2	$2.42K	Hold	278	–	–	﹤0.01%	5312
2025 Q1	$6.61K	Hold	278	–	–	﹤0.01%	5216
2024 Q4	$8K	Hold	278	–	–	﹤0.01%	5188
2024 Q3	$10.2K	Hold	278	–	–	﹤0.01%	4984
2024 Q2	$10.2K	Hold	278	–	–	﹤0.01%	5070
2024 Q1	$12.6K	Hold	278	–	–	﹤0.01%	5065
2023 Q4	$12.2K	Hold	278	–	–	﹤0.01%	5132
2023 Q3	$9.33K	Hold	278	–	–	﹤0.01%	5204
2023 Q2	$14.1K	Hold	278	–	–	﹤0.01%	5231
2023 Q1	$30.3K	Hold	278	–	–	﹤0.01%	5196
2022 Q4	$33.1K	Hold	278	–	–	﹤0.01%	5311
2022 Q3	$46K	Hold	278	–	–	﹤0.01%	5378
2022 Q2	$56K	Sell	278 -113	-29%	-$28.2K	﹤0.01%	5391
2022 Q1	$146K	Buy	391 +47	+14%	+$17.9K	﹤0.01%	5193
2021 Q4	$136K	Buy	344 +2	+0.6%	+$1.15K	﹤0.01%	5191
2021 Q3	$245K	Sell	342 -84	-20%	-$64.1K	﹤0.01%	4936
2021 Q2	$410K	Buy	426 +103	+32%	+$93.1K	﹤0.01%	4742
2021 Q1	$290K	Hold	323	–	–	﹤0.01%	4682
2020 Q4	$244K	Hold	323	–	–	﹤0.01%	4448
2020 Q3	$310K	Hold	323	–	–	﹤0.01%	4337
2020 Q2	$257K	Hold	323	–	–	﹤0.01%	4326
2020 Q1	$228K	Hold	323	–	–	﹤0.01%	4209
2019 Q4	$290K	Buy	323 +322	+32,200%	+$295K	﹤0.01%	4266
2019 Q3	$2K	Hold	1	–	–	﹤0.01%	4884
2019 Q2	$6K	Hold	1	–	–	﹤0.01%	4808
2019 Q1	$6K	Hold	1	–	–	﹤0.01%	4731
2018 Q4	$7K	Hold	1	–	–	﹤0.01%	4705
2018 Q3	$10K	Hold	1	–	–	﹤0.01%	4725
2018 Q2	$35K	Sell	1 -1	-50%	-$47.6K	﹤0.01%	4601
2018 Q1	$91K	Hold	2	–	–	﹤0.01%	4354
2017 Q4	$97K	Hold	2	–	–	﹤0.01%	4340
2017 Q3	$116K	Hold	2	–	–	﹤0.01%	4339
2017 Q2	$353K	Hold	2	–	–	﹤0.01%	4112
2017 Q1	$495K	Buy	+2	New	+$617K	﹤0.01%	3958
2016 Q4	–	Hold	0	–	–	–	3795
2016 Q3	–	Hold	0	–	–	–	3740
2016 Q2	–	Hold	0	–	–	–	3798
2015 Q2	–	Hold	0	–	-$2K	–	3262
2015 Q1	–	Hold	0	–	–	–	3129
2014 Q4	–	Hold	0	–	–	–	3146
2014 Q3	–	Hold	0	–	–	–	3163
2014 Q2	–	Hold	0	–	–	–	3141
2014 Q1	–	Hold	0	–	–	–	3047
2013 Q4	–	Hold	0	–	–	–	3047
2013 Q3	–	Hold	0	–	–	–	3039
2013 Q2	–	Hold	0	–	–	–	3085

Other funds holding PSTV

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's PSTV Position: Q1 2026 in Review

BlackRock held its Plus Therapeutics (PSTV) position steady in Q1 2026 at 71,055 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #4663.

BlackRock first reported a position in PSTV in Q1 2017 and has held it in 37 quarters since. The position peaked at $910K in Q4 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

BlackRock held 71,055 shares of Plus Therapeutics worth $289K as of Q1 2026.
BlackRock left its Plus Therapeutics share count unchanged in Q1 2026.
Plus Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4663 holding.
BlackRock first reported a position in Plus Therapeutics in Q1 2017 and has held it in 37 quarters since.
BlackRock's Plus Therapeutics position peaked at $910K in Q4 2025.
23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.